Feb 27, 2024 | GroveStreet, In the News
GroveStreet has been an investor in Foundry since 2013. One of Foundry’s early investments was Rover, a company that has grown to become the world’s largest online marketplace for pet care. Foundry led the company’s Series B valuing the company at $7M. Rover went public in August 2021 via a SPAC and was valued at $1.35B. In February of 2024 Blackstone acquired Rover in an all-cash take-private deal valuing the company at approximately $2.3B. Foundry has fully realized its investment in Rover. Read more about the deal here.
Learn more about us or reach out to schedule a meeting.
Nov 9, 2023 | GroveStreet, In the News
GroveStreet Principal, Patrick Sherwood, joined other LPs for the keynote address at the Global Private Capital Association Investors Meeting. The panel discussed both the challenges investors face as well as the opportunities that exist in today’s environment. Patrick discussed the attributes GroveStreet looks for in GPs to be able to navigate and generate returns in the current markets. He closed the discussion by describing some of the areas the GroveStreet team is pursuing across venture capital and buyout, including the opportunities created by innovative technologies and changes to the geopolitical landscape.
Learn more about us or reach out to schedule a meeting.
Nov 9, 2023 | GroveStreet, In the News
Mergermarket’s Chief Data Officer Giovanni Amodeo explores best practices in building private equity portfolios with GroveStreet Managing Director, John Merrill. In a broad ranging discussion, John tackles a range of questions that illuminate the attributes GroveStreet seeks in GPs. Watch the full interview here: https://ionanalytics.com/insights/mergermarket/john-merrill-senior-executive-at-grove-street-on-building-private-equity-portfolios/?utm_source=linkedin&utm_medium=social&utm_campaign=ion_analytics_influencers
Nov 8, 2023 | GroveStreet, In the News
GroveStreet Managing Director, John Merrill, moderated a panel of GPs exploring sectors of opportunity in venture capital beyond the AI frenzy. The group explored evolving investment themes in the areas of biotech, healthtech and fintech in North America as well as other innovation centers around the globe. Panelists debated whether or not there is a ‘new dawn’ for biotech or if the current period is just another stage in more of a linear evolution of the space. John wrapped up the discussion by querying the GPs about how they might construct a venture allocation if they were in the seat of a Chief Investment Officer. Not surprisingly, the GPs were bullish on the opportunities in venture.
Oct 31, 2023 | GroveStreet, In the News
Ted Seides of Capital Allocators interviews Managing Partner Bruce Ou. They discuss GroveStreet’s distinct qualities and edge as well as best practices in private market investing. Ted and Bruce also explore the origins of GroveStreet, when the founders saw an opportunity to partner with a select group of blue-chip investors to invest in the less efficient segments of private equity in a highly aligned way. Listen to the episode below, or wherever you get your podcasts.
Also available on: Apple Podcasts, Spotify, Google Podcasts, YouTube, or wherever you get your podcasts
Oct 17, 2023 | GroveStreet, In the News
As LPs have flocked to co-investments, GPs have responded with an ample supply of opportunities. Managing Partner Bruce Ou and Principal Patrick Sherwood examine best practices in co-investing and note fundamental tenets investors should have top of mind when building a co-investment strategy. The paper builds on recent research from Josh Lerner of Harvard Business School. Josh, a Senior Advisor to GroveStreet, offers academic grounding to the intuitions of experienced practitioners. Read more here
